1800 202 8726
Biopsy accuracy

Can a Biopsy — Miss Cancer?

A biopsy gives your doctor a piece of tissue to examine under a microscope. If the needle samples tissue beside the tumour rather than within it, the result can come back benign even when cancer is present.

Medically reviewed by Dr. Mohammed Imaduddin, Surgical Oncologist, MBBS · MS (General Surgery) · M.Ch (Surgical Oncology) · Last reviewed September 2026

  • It is a geometry problem — The needle targets what looks abnormal on a scan, but may collect tissue from a normal area close by.
  • Image guidance reduces the risk — Biopsies done under live ultrasound or CT are more likely to sample the right area.
  • Results are never read alone — Your oncologist compares the pathology against your imaging and clinical examination.
  • Concern after a benign result is valid — If symptoms persist or a lump remains, say so at your next appointment.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Yes, a biopsy can miss cancer. This happens when the needle samples tissue near but not within the tumour — a problem called sampling error. How likely it is depends on the tumour's size, location, and whether imaging guidance was used. A reassuring result should always be interpreted alongside your scan and clinical examination, not read in isolation.

What do these terms mean?

False negative
A result that says no cancer was found when cancer is actually present. The tissue was not misread — the cancerous area was not sampled.
Sampling error
When the needle collects tissue from a normal area near the tumour rather than from within it. This can happen even when the needle is in the right general location.
Discordant result
When the biopsy and the imaging tell different stories — for example, the scan suggests cancer but the pathology says benign. This mismatch requires further investigation, not reassurance.
Image-guided biopsy
A biopsy performed with live ultrasound, CT, or MRI to direct the needle into the target in real time. It reduces sampling error substantially but does not eliminate it.

When is a false negative more likely?

  • The lesion is small and harder to target with a needle
  • The lesion is deep in the body or near structures that limit needle access
  • The biopsy was done without imaging guidance
  • Only one or two samples were taken from a large or complex lesion
  • The tumour has mixed areas and the needle happened to sample a normal-looking zone
  • The edge of the lesion on imaging was not clearly defined

What should you do if your result still worries you?

  1. Describe what still concerns you

    Tell your oncologist the specific symptom, lump, or finding that led to the biopsy. A benign result does not automatically mean your concern was wrong.

  2. Ask how the result fits the whole picture

    Request an explanation of how the pathology compares with your imaging and clinical examination. If they are not consistent, that discordance needs a direct answer.

  3. Ask about a repeat or different biopsy

    If the result and the scan do not match, your doctor can arrange a repeat biopsy, samples from a different site, or a surgical excision that removes the entire area for examination.

  4. Request a second pathology opinion

    A different pathologist reading the same slides is standard practice when there is genuine doubt. Your oncologist can arrange it. You do not need to be certain something is wrong to ask.

  5. Keep all follow-up appointments

    Follow-up imaging at intervals exists precisely to catch anything a single biopsy may have missed. Attend those appointments and report any change in symptoms between them.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Why does a biopsy sometimes miss cancer?

Because the needle collects only a small piece of tissue, it can miss the abnormal area if the tumour is uneven or if the sample comes from the edge of the lesion rather than its centre.

Tumours are not uniform. Different zones within the same cancer can look completely normal under a microscope, and when the needle samples one of those zones, the result reads as benign. This is sampling error — not a sign the procedure was done badly, but a physical limitation of taking a small sample from a complex target.

Small and deeply located lesions are harder to reach precisely. Live imaging guidance during the procedure reduces this risk substantially, which is why it is used as standard for most diagnostic biopsies in oncology today.

How do doctors check whether a benign result is correct?

Your oncologist does not treat a biopsy result as a standalone verdict. It is compared against what your imaging showed, what was found on clinical examination, and what your symptoms suggest.

When the pathology and the imaging agree, a benign result is more reliable. When they disagree — the scan looks suspicious but the biopsy is normal — that is called a discordant result. Guidance from NCCN and ASCO is clear that discordant results require further evaluation, not reassurance.

If your symptoms continue or worsen after a benign result, go back and say so. That is exactly the information your team needs to decide whether a repeat biopsy is warranted.

Did you know?

Some cancers grow in multiple separate areas of the same organ at the same time. A single biopsy targeting one area can miss a second focus entirely — which is one reason NCCN guidelines for several cancer types recommend systematic sampling rather than a single pass.

The biopsy provides one piece of evidence. The imaging, the examination, and the follow-up provide the rest.

Source: NCCN Clinical Practice Guidelines

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

How often does a biopsy give a false negative result?

There is no single figure that applies across all biopsy types, organs, and lesion sizes, and any number you read should be understood as a range for a specific technique in a specific setting. What NCCN and ASCO guidance consistently emphasises is that false negative risk is exactly why biopsy results are always interpreted alongside imaging and clinical findings — not as a standalone answer. If you want to understand the false negative rate for your specific procedure, ask your oncologist directly.

My biopsy was benign but I still have a lump. What should I do?

Go back and say so. A benign result that does not explain a persistent clinical finding is exactly the kind of discordance that warrants further investigation. Ask your oncologist whether the pathology is consistent with what the imaging showed. If the two do not match, a repeat biopsy or a different sampling technique is a reasonable next step — not something you have to argue for, but a standard part of the diagnostic process.

Can I ask for a second opinion on my biopsy slides?

Yes, and it is entirely standard. A second pathologist reading the same tissue is a normal part of oncology practice. It is particularly worth considering when the result was described as borderline or atypical, when it does not match your imaging, or when you were told the cells looked unusual but not clearly malignant. Ask your oncologist to arrange it. Most will do so without hesitation if you explain your concern.

Does a false negative mean the pathologist made a mistake?

Not usually. A false negative most often means the needle collected tissue from an area that was genuinely normal — the sample was read accurately, but it was not representative of the most abnormal part of the lesion. The pathologist reads what they are given. This is why imaging guidance, the number of samples taken, and the match between pathology and imaging all matter. It is a limitation of sampling, not an error in reading.

Is image-guided biopsy always used?

Image guidance — using live ultrasound, CT, or MRI during the procedure — is the standard approach for most suspicious lesions in oncology today. Whether it was used for your biopsy, and which imaging method was chosen, is something your oncologist or the doctor who performed the procedure can confirm. If you are not sure, ask. If guidance was not used and your result concerns you, that is worth raising at your next appointment.

If cancer is missed once, can it be caught at a follow-up?

Yes, and this is one of the reasons follow-up imaging is scheduled even after a benign biopsy. A lesion that was too small or poorly positioned to sample accurately the first time will often be more visible — and more accessible — at the next scan. Attending those follow-up appointments, and telling your team about any change in your symptoms between them, is the safest way to ensure that a false negative does not delay a diagnosis.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation